SkyTech Orion Global Corp. (CTGL)
OTCMKTS
· Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
At close: Apr 27, 2026
SkyTech Orion Global Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
29.29M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wenyuan Group | -7.68K |
| Elamex SA de CV | 110.74M |
| Global Pharmatech | 3.18M |
| Limitless X Holdings | 946.56K |
| DAVIDsTEA | 43.33M |
| Havana Roasters Coffee Companies | 171.26K |
| Hanover Foods | 330.81M |
| Starco Brands | 40.48M |
SkyTech Orion Global News
- 4 months ago - SkyTech Orion Global Corp. (CTGL), Operating Under Citrine Global Corp., Positioned Ahead of Market as Global Demand Accelerates for Western, Scalable Small-Drone Solutions - GlobeNewsWire
- 5 months ago - Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (CTGL) announces CEO Ora Elharar Soffer as a UVID 2025 keynote speaker and will showcase the SkyTech Replicator™ modular drone platform and SkyTech Center, Israel's UAV hub - GlobeNewsWire
- 6 months ago - Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) Participates at AUVSI Defense 2025 Held in Washington, D.C., Launching SkyTech Replicator™, A Revolutionary Modular Drone that Transforms into 4 Different Mission Drones - GlobeNewsWire
- 6 months ago - Citrine Global Corp. (DBA SkyTech Orion Global Corp.) (OTCQB: CTGL) today issued a shareholder update letter from the Company's Chairwoman and Chief Executive Officer, Ora Elharar-Soffer - GlobeNewsWire
- 2 years ago - Citrine Global Corp. (CTGL) Announces Binding Agreement to Acquire 51% of iBOT Israel Botanicals, a Revenue-Generating Nutritional Supplements' Company with Fast-Growing Potential - GlobeNewsWire
- 3 years ago - Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant's Shares against Citrine Global Shares - GlobeNewsWire
- 3 years ago - Citrine Global Corp. (OTCQB: CTGL) Files Provisional Patent Application for Balancing Side Effects - GlobeNewsWire
- 4 years ago - Citrine Global Corp. (OTCQB: CTGL) Announced its Subsidiary Files Provisional Patent Application Targeting to Address Oral Cavity Side Effects Associated with the Use of Medicines, Treatments, Aging or an Unbalanced/Unhealthy Lifestyle - GlobeNewsWire